Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (F30AA024680, 5R01AA017729-05)
Received: 8 May 2020
Accepted: 30 September 2020
First Online: 9 October 2020
Ethics approval and consent to participate
: All animal studies were approved by the Institutional Animal Care and Use Committee at the University of Massachusetts Medical School (UMMS). All the methods were carried out in accordance with the approved guidelines.
: Not applicable.
: Dr. Szabo consults for Allergan, Alnylam, Arrow, Durcect Corporation, Generon, Glympse Bio, Terra Firma, Quest Diagnostsics, Pandion Therapeutics, Surrozen, and Zomagen. She has received grants from Gilead, Genfit, Intercept, Novartis, SignaBlok, and Shire. She holds intellectual property rights with Up to Date. The co-authors declare no competing financial interests.